C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2002
08/22/2002	WO2002064799A2 Optimized messenger rna
08/22/2002	WO2002064795A2 Putative human enzymes
08/22/2002	WO2002064792A2 Molecules for disease detection and treatment
08/22/2002	WO2002064791A2 Proteins and nucleic acids encoding same
08/22/2002	WO2002064788A2 Compositions and methods relating to lung specific genes and proteins
08/22/2002	WO2002064787A1 Neurotonin and use thereof
08/22/2002	WO2002064785A1 NOVEL CLOCK GENE Bmal2
08/22/2002	WO2002064773A2 Method for high throughput screening of candidate compounds by high throughput direct synthesis of recombinant polypeptides
08/22/2002	WO2002064770A1 Novel scavenger receptor class a protein
08/22/2002	WO2002064757A2 Influenza viruses with enhanced transcriptional and replicational capacities
08/22/2002	WO2002064731A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/22/2002	WO2002064634A2 Human monoclonal antibodies to fc alpha receptor (cd89)
08/22/2002	WO2002064629A2 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof
08/22/2002	WO2002064626A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
08/22/2002	WO2002064622A1 Method for purifying the helicobacter adhesin-like protein a (alpa)
08/22/2002	WO2002064621A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
08/22/2002	WO2002064615A2 Monoclonal antibodies to human immunodeficiency virus and uses thereof
08/22/2002	WO2002064612A2 Human g-protein chemokine receptor (ccr5) hdgnr10
08/22/2002	WO2002064161A2 Method and compositions for immunization with the pseudomonas v antigen
08/22/2002	WO2002015939A3 Calycins
08/22/2002	WO2002002773A3 Dual specificity antibodies and methods of making and using
08/22/2002	WO2001085204A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
08/22/2002	WO2001085203A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
08/22/2002	WO2001074903A3 Cd20/ige-receptor like molecules and uses thereof
08/22/2002	WO2000036092A9 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION
08/22/2002	WO2000032239A9 Hapten-carrier conjugates for treating and preventing nicotine addiction
08/22/2002	WO2000020449A9 MODIFIED TGF-β SUPERFAMILY PROTEINS
08/22/2002	WO1999058143A9 Utilization of interferon alpha 5 in the treatment of viral hepatopathies
08/22/2002	US20020116724 Nucleotide sequences codingolypeptide for use in the diagnosis and prevention of psoriasis and venous ulcers
08/22/2002	US20020115849 Plant promoter activated by fungal infection
08/22/2002	US20020115848 IBD-associated microbial nucleic acid molecules
08/22/2002	US20020115847 Nuclear receptor of given amino acid sequence; receptor modulates 9-cis retinoic acid signalling
08/22/2002	US20020115834 New process for the production of biologically active protein
08/22/2002	US20020115833 Glycoprotein for use in the treatment of kidney and blood disorders
08/22/2002	US20020115829 Pathogenic escherichia coli associated protein
08/22/2002	US20020115827 Stabilizaton of heat resistant protein; obtain protein, replace aspartic acids with glutamic acids, recover protein
08/22/2002	US20020115610 Isolated polypeptides that stimulate gastrointestinal smooth muscle contraction, including human; ionotropic agents; enhanced gastrointestinal motility; identifying a prokineticin receptor ligand; calcium mobilization
08/22/2002	US20020115597 Antibiotics GE 23077, pharmaceutically acceptable salts and compositions, and use thereof
08/22/2002	US20020115223 In vitro system for determining formation of abeta amyloid
08/22/2002	US20020115203 Proteins for use in the treatment infectious, cancers and autoimmune disease
08/22/2002	US20020115191 KdtB
08/22/2002	US20020115187 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent
08/22/2002	US20020115166 Peptide for use in the treatment of pancreatic defects
08/22/2002	US20020115156 Connective tissue growth factor for use in the treatment of cancer, fibrotic defects and atherosclerosis; for use as wound healing agents
08/22/2002	US20020115154 Trail receptors, nucleic acids encoding the same, and methods of use thereof
08/22/2002	US20020115152 Expression system for factor VIII
08/22/2002	US20020115151 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment
08/22/2002	US20020115146 Method of protein synthesis
08/22/2002	US20020115145 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/22/2002	US20020115141 Method for improved production of cyanophycin and secondary products thereof
08/22/2002	US20020115140 Nucleotide sequences coding preferential polypeptide for use in treatment of immmunological defects
08/22/2002	US20020115138 Nucleotide sequences coding transport protein for use in treat ment of tumors
08/22/2002	US20020115135 Synapse related glycoproteins
08/22/2002	US20020115110 Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2
08/22/2002	US20020115108 Enzymes having high temperature polymerase activity and methods of use thereof
08/22/2002	US20020115064 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease
08/22/2002	US20020114811 Contacting body fluid from mammal with antibody which binds to human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide under conditions sufficient to form antigen-antibody complex and detecting complex
08/22/2002	US20020114810 Diagnosis and treatment of malignant neoplasms statement as to federally sponsored research
08/22/2002	US20020114801 Heparanase specific molecular probes and their use in research and medical applications
08/22/2002	DE10108212A1 Fusionsprotein zur Sekretion von Wertprotein in bakterielle Überstände Fusion protein for secretion of value protein in bacterial supernatants
08/22/2002	DE10108211A1 Verwendung von Fusionsproteinen, deren N-terminaler Anteil aus einem Hirudinderivat besteht, zur Herstellung rekombinanter Proteine über Sekretion durch Hefen Use of fusion proteins whose N-terminal portion consists of a hirudin derivative for the production of recombinant proteins via secretion by yeasts
08/22/2002	DE10106339A1 Verfahren zum Hochdurchsatz-Screening von Kandidaten-Verbindungen über die Hochdurchsatz-Direktsynthese von rekombinanten Polypeptiden A method for high-throughput screening of candidate compounds on the high-throughput direct synthesis of recombinant polypeptides
08/22/2002	CA2854685A1 Optimized messenger rna
08/22/2002	CA2441464A1 Novel scavenger receptor class a protein
08/22/2002	CA2438658A1 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
08/22/2002	CA2438219A1 Sequences involved in phenomena of tumour suppression, tumour reversion apoptosis and/or virus resistance and their use as medicines
08/22/2002	CA2438215A1 Putative human enzymes
08/22/2002	CA2438125A1 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
08/22/2002	CA2437873A1 Neurotonin and use thereof
08/22/2002	CA2437811A1 Human g-protein chemokine receptor (ccr5) hdgnr10
08/22/2002	CA2436889A1 Method for purifying the helicobacter adhesin-like protein a (alpa)
08/22/2002	CA2436713A1 Proteins and nucleic acids encoding same
08/22/2002	CA2433843A1 Molecules for disease detection and treatment
08/22/2002	CA2430726A1 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof
08/22/2002	CA2427112A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
08/21/2002	EP1233066A2 Peptide vector
08/21/2002	EP1233065A1 G-CSF analog compositions and methods
08/21/2002	EP1233064A1 Modified factor VIII cDNA and its use for the production of factor VIII
08/21/2002	EP1233059A1 Influenza viruses with enhanced transcriptional and replicational capacities
08/21/2002	EP1233026A1 Antibody against rat postacrosome reaction sperm and utilization thereof
08/21/2002	EP1233023A1 Transcription factor and dna thereof
08/21/2002	EP1232396A2 Assay of isomerised and/or optically inverted proteins
08/21/2002	EP1232394A1 Sandwich immunoassay and monoclonal antibodies for comp, cartillage oligomeric matrix protein
08/21/2002	EP1232269A1 Method for purifying proteins
08/21/2002	EP1232266A2 Polypeptides and nucleic acids encoding same
08/21/2002	EP1232265A2 G-protein coupled receptor htogh35
08/21/2002	EP1232264A2 Human fgf-21 gene and gene expression products
08/21/2002	EP1232263A2 Polypeptides and nucleic acids encoding same
08/21/2002	EP1232262A2 Recombinant gelatin in vaccines
08/21/2002	EP1232245A1 Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders
08/21/2002	EP1232182A2 Animal collagens and gelatins
08/21/2002	EP1232181A2 Recombinant gelatins
08/21/2002	EP1232180A1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues
08/21/2002	EP1232179A1 15 human secreted proteins
08/21/2002	EP1232178A2 Compositions and methods for regulating tumor-associated antigen expression
08/21/2002	EP1232177A2 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides
08/21/2002	EP1231943A1 Interferon gamma conjugates
08/21/2002	EP1231937A2 Tr3-specific binding agents and methods for their use
08/21/2002	EP1231930A1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS
08/21/2002	EP1231836A2 Human ex vivo immune system

1 ... 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 ... 1125